EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monitoring Cytogenetic Effects in Peripheral Blood Lymphocytes of Thyroid Cancer Patients Receiving Radioiodine Treatment

Igor K Khvostunov, Elena Nasonova iD, Pavel Lobachevsky iD, Valeriy Krylov, Andrei Shurinov, Andrei Rodichev iD, Olga Korovchuk, Anna Geraskina, Ekaterina Shipilova, Petr Shegai, Andrei Kaprin

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27094049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Igor K Khvostunov und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Biophysics, A. Tsyb Medical Radiological Research Center (MRRC)-Branch of the National Medical Research Radiological Center o…. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Thyroid Neoplasms, Lymphocytes, Chromosome Aberrations. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Institute for Nuclear Research, JINR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated cytogenetic damage in peripheral blood lymphocytes of 10 differentiated thyroid cancer patients who received multiple 131I radioiodine (RAI) treatments following total thyroidectomy. Blood samples were collected before the RAI therapy course and 2–3 days after the course for a few selected courses (from 1 to 3) for each patient. The cumulative average number of chromosome aberrations (CAs) per cell and its increment due to a selected RAI course were evaluated using the multiplex fluorescence in situ hybridization method (mFISH). An increase in the number of CAs was observed with the accumulation of RAI activity. The yield of these CAs per unit of accumulated RAI activity was, however, approximately three-fold lower than the respective yield for the incremented number of CAs in a selected course, thus demonstrating the elimination of CAs and/or aberrant cells with time. Biological dosimetry was performed based on the number of all types of CAs and in vitro mFISH calibration curves. With an average administered RAI activity of 3.40 ± 0.39 GBq, the average absorbed blood dose was 0.61 Gy (0.31–0.89:95% CI). Our results demonstrate that one-time administration of such activities of RAI was safe, since the commonly accepted threshold of 2 Gy for the blood dose was not exceeded.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iodine RadioisotopesThyroid NeoplasmsLymphocytesChromosome AberrationsHumansMaleFemaleMiddle AgedAdultIn Situ Hybridization, FluorescenceAged

Stichwörter der Autor:innen

adverse effectbiological dosimetryblood lymphocyte dosechromosome aberrationsiodine-131multiplex fluorescence in situ hybridizationradioiodine therapythyroid cancer

Substanzen

Iodine RadioisotopesIodine-131

Autor:innen und Institutionen

  • Department of Radiation Biophysics, A. Tsyb Medical Radiological Research Center (MRRC)-Branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation (NMRRC), 10, Marsha…
  • Laboratory of Radiation Biology, Joint Institute for Nuclear Research (JINR), 6 Joliot-Curie St., 141980 Dubna, Moscow Region, Russia.
  • Department of Biophysics, Faculty of Natural Sciences and Engineering, Dubna State University (DSU), Universitetskaya St. 19, 141980 Dubna, Moscow Region, Russia.
  • National Medical Research Radiological Center of the Ministry of Health of the Russian Federation (NMRRC), 4, Korolev St., 249036 Obninsk, Kaluga Region, Russia.
  • Medical Institute, Peoples' Friendship University of Russia (RUDN University), 6, Miklukho-Maklaya St., 117198 Moscow, Russia.

ORCID-Profile: Elena Nasonova, Pavel Lobachevsky, Andrei Rodichev

Förderung

  • Joint Institute for Nuclear Research
  • JINR

Zitieren

APA

Khvostunov, I. K., Nasonova, E., Lobachevsky, P., Krylov, V., Shurinov, A., Rodichev, A., Korovchuk, O., Geraskina, A., Shipilova, E., Shegai, P., & Kaprin, A. (2026). Monitoring Cytogenetic Effects in Peripheral Blood Lymphocytes of Thyroid Cancer Patients Receiving Radioiodine Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27094049

Vancouver

Khvostunov IK, Nasonova E, Lobachevsky P, Krylov V, Shurinov A, Rodichev A, et al. Monitoring Cytogenetic Effects in Peripheral Blood Lymphocytes of Thyroid Cancer Patients Receiving Radioiodine Treatment. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27094049

BibTeX
@article{Khvostunov2026,
  author = {Khvostunov, Igor K and Nasonova, Elena and Lobachevsky, Pavel and Krylov, Valeriy and Shurinov, Andrei and Rodichev, Andrei and Korovchuk, Olga and Geraskina, Anna and Shipilova, Ekaterina and Shegai, Petr and Kaprin, Andrei},
  title = {Monitoring Cytogenetic Effects in Peripheral Blood Lymphocytes of Thyroid Cancer Patients Receiving Radioiodine Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27094049}
}
Kostenlos starten →